3rd-Party Lab Tested Every batch is independently tested for purity and quality
The trial team can explain study-related visits, possible reimbursements, travel expectations, and any participant costs
4 Clinical evidence in T2DM management A wide range of clinical trials and research have been performed to assess the effectiveness, safety, and tolerability of short-acting against long-acting GLP-1 analogues in the treatment and management of T2DM and obesity
Allow the vial to reach room temperature before opening
Semaglutide: GLP-1 Only Semaglutide mimics glucagon-like peptide-1, a gut hormone that slows gastric emptying, reduces appetite through hypothalamic signaling, enhances insulin secretion, and suppresses glucagon release